Role of Emotional Freedom Techniques in Reducing Postoperative Nausea and Vomiting After Laparoscopic Cholecystectomy

NCT02169856 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2014-06-23

No results posted yet for this study

Summary

In our study the investigators want to evaluate the effects of EFTs (emotional freedom techniques) for reducing incidence of PONV (Postoperative nausea and vomiting). The effects of EFTs have been quiet evident on many aspects if the incidence of PONV is reduced then it will be much valuable adjunct to postoperative management of the patients.

Our hypothesis was Emotional freedom techniques are very useful to reduce the incidence of postoperative nausea and vomiting after laparoscopic cholecystectomy.

Conditions

  • Postoperative Nausea and Vomiting

Interventions

BEHAVIORAL

EFTs (emotional freedom techniques)

The Emotional Freedom Techniques (EFTs) which has been pioneered by Gary Craig is a form of alternate medicine which works by tapping on body energy meridian points. Unlike drugs the EFTs has no side effects too

DRUG

Tab. Midazolam 7.5 mg

Tab. Midazolam 7.5 mg will be given to all patients at night before surgery.

DRUG

Inj. Midazolam 0.7mg/kg

Inj . Midazolam 0.7 mg/kg given as premedication 45 min before surgery.

DRUG

Inj. Propofol 2.5mg/kg

It was given to induce anesthesia after 3 min of pre oxygenation.

DRUG

Inj. Atracurium 0.5 mg/kg

It was given to induce muscle relaxation during anesthesia

DRUG

Sevoflurane 2.5 vol %

It was given to maintain anesthesia during surgery alongwith oxygen in air mixture

DRUG

Inj. Cefuroxime 1.5 g IV

It was given as prophylactic antibiotic. 2 doses given. 1st 30-60 min before surgery. 2nd 6 hours after surgery

DRUG

Drug: Inj. Ketorolac 30 mg IV

3 doses for analgesia. 1st immediate postoperative, 2nd at 8 hours postoperative and 3 rd at 16 hours postoperative period

DRUG

Inj. Zantac 50mg IV

2 doses. 1st at immediate postoperative and 2nd 12 hours after surgery

Sponsors & Collaborators

  • Benazir Bhutto Hospital, Rawalpindi

    lead OTHER_GOV

Principal Investigators

  • Fazal H Shah, FCPS I · Benazir Bhutto Hospital, Rawalpindi

  • Aurangzeb Khan, FCPS · Benazir Bhutto Hospital, Rawalpindi

  • Jahangir S Khan, FCPS, FACS · Benazir Bhutto Hospital, Rawalpindi

  • Muhammad B Habshi, FCPS I · Benazir Bhutto Hospital, Rawalpindi

  • Muhammad Z Saeed, FCPS I · Benazir Bhutto Hospital, Rawalpindi

  • Sheikh F Riaz, FCPS I · Benazir Bhutto Hospital, Rawalpindi

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
25 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-07-31
Primary Completion
2014-02-28
Completion
2014-02-28

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02169856 on ClinicalTrials.gov